GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » ROE %

Tecogen (Tecogen) ROE % : -47.24% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Tecogen ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Tecogen's annualized net income for the quarter that ended in Dec. 2023 was $-7.38 Mil. Tecogen's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $15.63 Mil. Therefore, Tecogen's annualized ROE % for the quarter that ended in Dec. 2023 was -47.24%.

The historical rank and industry rank for Tecogen's ROE % or its related term are showing as below:

TGEN' s ROE % Range Over the Past 10 Years
Min: -55.83   Med: -18.58   Max: 19.19
Current: -27.06

During the past 13 years, Tecogen's highest ROE % was 19.19%. The lowest was -55.83%. And the median was -18.58%.

TGEN's ROE % is ranked worse than
92.59% of 2954 companies
in the Industrial Products industry
Industry Median: 7.1 vs TGEN: -27.06

Tecogen ROE % Historical Data

The historical data trend for Tecogen's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecogen ROE % Chart

Tecogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.45 -30.32 19.19 -12.15 -27.17

Tecogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.82 -32.41 -18.03 -11.53 -47.24

Competitive Comparison of Tecogen's ROE %

For the Electrical Equipment & Parts subindustry, Tecogen's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tecogen's ROE % Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Tecogen's ROE % distribution charts can be found below:

* The bar in red indicates where Tecogen's ROE % falls into.



Tecogen ROE % Calculation

Tecogen's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-4.598/( (19.094+14.747)/ 2 )
=-4.598/16.9205
=-27.17 %

Tecogen's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-7.384/( (16.517+14.747)/ 2 )
=-7.384/15.632
=-47.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Tecogen  (OTCPK:TGEN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-7.384/15.632
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-7.384 / 23.592)*(23.592 / 28.49)*(28.49 / 15.632)
=Net Margin %*Asset Turnover*Equity Multiplier
=-31.3 %*0.8281*1.8225
=ROA %*Equity Multiplier
=-25.92 %*1.8225
=-47.24 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-7.384/15.632
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-7.384 / -7.312) * (-7.312 / -7.328) * (-7.328 / 23.592) * (23.592 / 28.49) * (28.49 / 15.632)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0098 * 0.9978 * -31.06 % * 0.8281 * 1.8225
=-47.24 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Tecogen ROE % Related Terms

Thank you for viewing the detailed overview of Tecogen's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecogen (Tecogen) Business Description

Traded in Other Exchanges
Address
45 First Avenue, Waltham, MA, USA, 02451
Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production. Products segment designs, manufactures and sells industrial and commercial cogeneration systems. Services segment provides operations and maintenance services and turn-key installation for products under long term service contracts. Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to the customers under long-term energy sales agreements.
Executives
Earl R Lewis director C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos director, 10 percent owner, officer: Chief Executive Officer 85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch director 280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh director, officer: Chief Financial Officer 45 FIRST AVE, WALTHAM MA 02451
John M Albertine director 100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown 10 percent owner, other: Trustee C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins director 45 FIRST AVE, WALTHAM MA 02451
Fred Holubow director
Locke M. Benjamin officer: Co-CEO 45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv officer: General Counsel & Secretary 49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen director 45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas 10 percent owner TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell director 6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson director C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison officer: CFO, Treasurer and Secretary C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420